Dynavax Technologies

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$95,442
$68,164
$72,032
$80,630
Gross Profit
81,407
54,395
58,622
67,546
EBITDA
24,896
-94,435
11,404
23,571
EBIT
22,857
-96,471
9,333
21,517
Net Income
18,721
-96,099
7,050
17,594
Net Change In Cash
95,442
68,164
72,032
80,630
Free Cash Flow
21,979
-23,567
49,533
18,121
Cash
99,101
51,720
95,883
119,332
Basic Shares
138,356
124,871
153,022
154,807

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$277,246
$232,284
$722,683
$439,442
Gross Profit
227,801
182,117
460,530
265,870
EBITDA
45,701
9,666
307,699
95,708
EBIT
37,649
2,390
301,031
88,697
Net Income
27,309
-6,389
293,156
76,713
Net Change In Cash
277,246
232,284
722,683
439,442
Cost of Revenue
-233,754
405,529
Free Cash Flow
60,160
96,459
55,577
326,051
Cash
95,883
150,279
202,004
436,189
Basic Shares
133,344
128,733
150,797
133,006

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
$0.14
2025-03-31
-$0.009
2024-12-31
$0.05